Document is current
Any future updates will be listed below
-
Authors
Zürcher, N. R. https://orcid.org/0000-0003-0271-6304
Loggia, M. L.
Mullett, J. E.
Tseng, C. https://orcid.org/0000-0003-0592-335X
Bhanot, A.
Richey, L.
Hightower, B. G.
Wu, C.
Parmar, A. J.
Butterfield, R. I.
Dubois, J. M.
Chonde, D. B.
Izquierdo-Garcia, D.
Wey, H. Y.
Catana, C.
Hadjikhani, N. https://orcid.org/0000-0003-4075-3106
McDougle, C. J.
Hooker, J. M.
- License Information
-
More Information
Article History
Received: 21 June 2019
Revised: 12 January 2020
Accepted: 6 February 2020
First Online: 19 February 2020
Compliance with ethical standards
:
: In the past year, Dr. Hooker has consulted for Psy Therapeutics, Amathus Therapeutics, Evelo Biosciences, Rodin Therapeutics, and the Alzheimer’s Drug Discovery Foundation. He is a co-founder and equity holder in Eikonizo Therapeutics and has received honoraria for speaking or advisory service at nonprofit academic institutions. Dr. Hadjikhani is a co-founder of Neurochlore. All other authors declare no conflicts of interest.
